ReviewJournal of diabetes research2025
Preventing and Managing Vascular Complications in Adolescents With Type 1 Diabetes.
Review in Journal of diabetes research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Gut microbiota-modulating interventions in paediatric type 1 diabetes: a systematic review and meta-analysis.European journal of pediatrics · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The morbidity and mortality associated with Type 1 diabetes are primarily linked to vascular complications. While overt clinical manifestations of microvascular complications and cardiovascular disease predominantly occur during adulthood, a noteworthy proportion of adolescents with Type 1 diabetes have one or more risk factors for the development of vascular complications. In addition, early subclinical stages of vascular complications can be detected already in youth with diabetes. Intensive diabetes management and targeted screening strategies can effectively delay or halt the progression of these complications. Preventative strategies should focus on three main principles: achieving optimal glycemic targets, preventing and targeting cardiometabolic risk factors, and implementing early screening programs. For managing complications, a comprehensive approach is essential, combining insulin therapy to optimize glycemic targets, motivational lifestyle interventions, and timely pharmacological treatments. This review summarizes the epidemiology and risk factors for vascular complications in youth with Type 1 diabetes and emphasizes the importance of early detection and prevention, and effective treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.